−£159k
−216%vs Apr 2024Active08032517Private limited companyForest Hill
HNS PHARMA LIMITED
Significant control: Hasmukh Manibhai Patel (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Hns Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
HNS PHARMA LIMITED is an active private limited company (company number 08032517) incorporated on 17 April 2012, registered in Forest Hill. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 29 April 2025, showing net assets of −£159k and cash of £163k, with 19 employees on average. Net assets fell 216% on the prior period (£137k).
Peer position · net assets
By net assets it sits in the bottom quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
02
Ownership and control
- Mr Hasmukh Manibhai Patel
- owns 50–75% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 April 201214 yrs ago
- Next accounts due
- 29 January 2027in 98 days
- Confirmation statement due
- 1 May 2027in 190 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£163k
−11%vs Apr 2024Not reported
19
+27%vs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 29 April 2025 | −£159k | £163k | £1.57m | — | — | — | 19 |
| 29 April 2024 | £137k | £183k | £1.13m | — | — | — | 15 |
Cash per employee£8,568Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-158,568 at 29 April 2025
- Net assets down 25% or more on the prior period-215.8% vs prior period
- Cash at bank of £50,000 or moreCash £162,792
- Incorporated five or more years agoIncorporated 17 April 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 190 days
- Next accounts duein 98 days
- Accounts period endNet liabilities £159k · small accounts
- Accounts period endNet assets £137k · small accounts
- Incorporated
08
Similar companies in London
- THLALA KOLO (UK) LTDLondon · inc. Mar 2012
- MITOCHONDRIAL THERAPY LTDLondon · inc. Feb 2012
- AMAXA PHARMA LTDLondon · inc. Jun 2012
- AEGERION PHARMACEUTICALS LIMITEDLondon · inc. Jun 2012
- ADAMS & CO LONDON LTDLondon · inc. Feb 2012
- KOOL PHARMA LIMITED45 Gresham Street · inc. Jul 2012
All companies incorporated on 17 April 2012 · in Apr 2012.
09
Reminders for HNS PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.